Forecast & Rating9 analysts currently cover BeOne Medicines, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is ¥364.41, about 24.0% upside from the current price of ¥293.78. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 59.1% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study BeOne Medicines closely still see room for the stock to rise. Data as of Aug 18, 2026; for reference only and not investment advice.
Aug 18, 2026Price forecast
¥364.4124.04%
Forecast & RatingStrong buy
9analysts
- Strong buy77.78%
- Buy22.22%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met49.1%
Stock price$293.78
Avg. target$364.4
High target$454
Low target$273
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.